FLRT3 and ovarian cancer: To translate in vitro Jurkat assay results to primary human T cells, previously activated human T cells were restimulated with Immunocult (anti-CD3 + anti-CD28 beads) in the presence of SKOV3 ovarian cancer cells that endogenously express FLRT3 for 3 days with NP591 or isotype control.